I am pleased to share my academic paper published in Intelligence-Based Medicine, available through ScienceDirect and indexed in Scopus.
The paper explores how governance frameworks can support the responsible use of artificial intelligence in genomic medicine, especially as healthcare institutions move from innovation to clinical application.
Read the full paper here:
Dr. Habib Al Souleiman is a researcher and educator who is passionate about AI, behavioural economics, consumer psychology and the human side of financial decision-making. He writes about how emotions, perception and timing affect the choices people make in markets, and how a better understanding of these forces can help to support wiser and more confident decisions. His work is dedicated to translating academic ideas into simple, practical lessons for students, professionals and ordinary readers, always with the goal of stimulating thoughtful, ethical and forward-looking engagement with the economy. He writes articles and thoughts on his website to let everyone learn about economics and human behavior.
Artificial Intelligence – Declaration on Use
The author used AI tools only to improve language and readability of this manuscript. All conceptual design, theoretical framing and analytical interpretation were done independently by the human author.
